Build status - In Progress
Search filters

Filters
Clear All

Phase

  • 2
  • 3
  • 4
  • 3
  • 14
  • 26
  • 16
  • 1
  • 2
  • 23
  • 25
  • 1

Found 26 hematology trials

A listing of hematology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

99 years or below
All genders
This study investigates the efficacy of an investigational medication in participants with diffuse glioma. The purpose is to understand how the medication works after radiotherapy and its effects on the tumor.The study focuses on evaluating the treatment's impact on health care resource use and measuring plasma concentrations to estimate pharmacokinetic …
99 years or below
All genders
To evaluate the efficacy of ONC201 administered following radiotherapy in participants with H3 K27Mmutant diffuse glioma. To assess plasma concentrations and estimate PK parameters for ONC201. To evaluate the efficacy of ONC201 using RANO-LGG criteria. To evaluate the impact of ONC201 treatment on health care resource utilization.
 Study of Daratumumab with Dose-Adjusted EPOCH in Newly Diagnosed Plasmablastic Lymphoma
18 years - 99 years
All genders
Patients with plasmablastic lymphoma are potential participants of this research trial. Patients with a type of B-cell non-Hodgkin lymphoma (NHL) will be invited from Penn Medicine practices. This research study is designed to test the safety of daratumumab, a drug added to the standard lymphoma treatment when given to individuals …
 Robotic Nipple Sparing Mastectomy (NSM) Study
18 years - 80 years
Female
Phase 3
The goal of this prospective study is to evaluate the safety and effectiveness of the da Vinci Xi Surgical System, instruments, and accessories in Nipple Sparing Mastectomy, otherwise known as NSM procedures.
99 years or below
All genders
Phase 2
Interventional
The main purpose of this study is to evaluate the efficacy and safety of the investigational drug iptacopan (LNP023) in people with primary ITP or primary CAD. You will be in the study about 6 months with the opportunity to extend the total duration to about 31 months if you …
 A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
18 years or above
All genders
Phase 1
Interventional
This is a first-in-human, multicenter, open-label, phase 1 study to evaluate the safety, PK, PD and preliminary efficacy of STX-0712 in patients with advanced CMML and AML for whom there are no further treatment options known to confer clinical benefit.
21 - 26 of 26